![Justin Renz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Justin Renz
Director of Finance/CFO at
ZEVRA THERAPEUTICS, INC.
Net worth: 2 M $ as of 30/06/2026
Profile
Justin A. Renz is currently Chief Financial Officer & Treasurer at Zevra Therapeutics, Inc. since 2026.
Formerly, Mr. Renz was Chief Operating Officer at Ardelyx, Inc. from 2025 to 2025; President & Chief Financial Officer at Correvio Pharma Corp.
from 2019 to 2020; Chief Financial Officer, Treasurer & Executive Vice President at Karyopharm Therapeutics, Inc. from 2015 to 2017; Chief Financial Officer, Treasurer, Senior Vice President & General Counsel at CombinatoRx, Inc. from 2010 to 2014; Chief Financial Officer & Executive Vice President at Zalicus Pharmaceuticals Ltd. from 2006 to 2014; Director-Accounting & Financial Operations at EMD Serono, Inc. in 2006; Senior Director-Global Accounting & Finance at Coley Pharmaceutical Group, Inc. in 2005; and held principal roles at EMD Millipore Corp., ArQule, Inc., and Arthur Andersen LLP.
Education includes undergraduate studies at College of the Holy Cross (Massachusetts), an MBA from Suffolk University, and graduate studies at Northeastern University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ARDELYX, INC. 0.17% | 31/03/2026 | 409,052 ( 0.17% ) | 2 M $ | 30/06/2026 |
Justin Renz active positions
| Companies | Position | Start |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Director of Finance/CFO | 09/03/2026 |
Former positions of Justin Renz
| Companies | Position | End |
|---|---|---|
| ARDELYX, INC. | Director of Finance/CFO | 04/11/2025 |
| CORREVIO PHARMA CORP. | Director of Finance/CFO | 27/05/2020 |
| KARYOPHARM THERAPEUTICS INC. | Director of Finance/CFO | 03/04/2017 |
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Director of Finance/CFO | 01/01/2014 |
Zalicus Pharmaceuticals Ltd.
 Zalicus Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for patients suffering from pain and immuno-inflammatory diseases | Director of Finance/CFO | 01/01/2014 |
Training of Justin Renz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
61
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
EMD Millipore Corp.
 EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services Engages in research, development and production of biotechnology & pharmaceutical drug therapies | Commercial Services |
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat chronic diseases | Health Technology |
Correvio Pharma Corp.
 Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company for commercializing cardiovascular hospital drugs | Health Technology |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Health Technology |
Zevra Therapeutics, Inc.
 Zevra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets proprietary prodrugs | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Suffolk University
 Suffolk University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Zalicus Pharmaceuticals Ltd.
Zalicus Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for patients suffering from pain and immuno-inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Justin Renz
